1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Tissue Chips Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Human Tissue Chips by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Human Tissue Chips by Country/Region, 2018, 2022 & 2029
2.2 Human Tissue Chips Segment by Type
2.2.1 Glass Materials
2.2.2 Silicone Materials
2.2.3 Polymers Materials
2.3 Human Tissue Chips Sales by Type
2.3.1 Global Human Tissue Chips Sales Market Share by Type (2018-2023)
2.3.2 Global Human Tissue Chips Revenue and Market Share by Type (2018-2023)
2.3.3 Global Human Tissue Chips Sale Price by Type (2018-2023)
2.4 Human Tissue Chips Segment by Application
2.4.1 Drug Discovery
2.4.2 Toxicity Testing
2.4.3 Disease Modeling
2.4.4 Personalized Medicine
2.5 Human Tissue Chips Sales by Application
2.5.1 Global Human Tissue Chips Sale Market Share by Application (2018-2023)
2.5.2 Global Human Tissue Chips Revenue and Market Share by Application (2018-2023)
2.5.3 Global Human Tissue Chips Sale Price by Application (2018-2023)
3 Global Human Tissue Chips by Company
3.1 Global Human Tissue Chips Breakdown Data by Company
3.1.1 Global Human Tissue Chips Annual Sales by Company (2018-2023)
3.1.2 Global Human Tissue Chips Sales Market Share by Company (2018-2023)
3.2 Global Human Tissue Chips Annual Revenue by Company (2018-2023)
3.2.1 Global Human Tissue Chips Revenue by Company (2018-2023)
3.2.2 Global Human Tissue Chips Revenue Market Share by Company (2018-2023)
3.3 Global Human Tissue Chips Sale Price by Company
3.4 Key Manufacturers Human Tissue Chips Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Tissue Chips Product Location Distribution
3.4.2 Players Human Tissue Chips Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Tissue Chips by Geographic Region
4.1 World Historic Human Tissue Chips Market Size by Geographic Region (2018-2023)
4.1.1 Global Human Tissue Chips Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Human Tissue Chips Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Human Tissue Chips Market Size by Country/Region (2018-2023)
4.2.1 Global Human Tissue Chips Annual Sales by Country/Region (2018-2023)
4.2.2 Global Human Tissue Chips Annual Revenue by Country/Region (2018-2023)
4.3 Americas Human Tissue Chips Sales Growth
4.4 APAC Human Tissue Chips Sales Growth
4.5 Europe Human Tissue Chips Sales Growth
4.6 Middle East & Africa Human Tissue Chips Sales Growth
5 Americas
5.1 Americas Human Tissue Chips Sales by Country
5.1.1 Americas Human Tissue Chips Sales by Country (2018-2023)
5.1.2 Americas Human Tissue Chips Revenue by Country (2018-2023)
5.2 Americas Human Tissue Chips Sales by Type
5.3 Americas Human Tissue Chips Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Tissue Chips Sales by Region
6.1.1 APAC Human Tissue Chips Sales by Region (2018-2023)
6.1.2 APAC Human Tissue Chips Revenue by Region (2018-2023)
6.2 APAC Human Tissue Chips Sales by Type
6.3 APAC Human Tissue Chips Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Tissue Chips by Country
7.1.1 Europe Human Tissue Chips Sales by Country (2018-2023)
7.1.2 Europe Human Tissue Chips Revenue by Country (2018-2023)
7.2 Europe Human Tissue Chips Sales by Type
7.3 Europe Human Tissue Chips Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Tissue Chips by Country
8.1.1 Middle East & Africa Human Tissue Chips Sales by Country (2018-2023)
8.1.2 Middle East & Africa Human Tissue Chips Revenue by Country (2018-2023)
8.2 Middle East & Africa Human Tissue Chips Sales by Type
8.3 Middle East & Africa Human Tissue Chips Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Tissue Chips
10.3 Manufacturing Process Analysis of Human Tissue Chips
10.4 Industry Chain Structure of Human Tissue Chips
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Tissue Chips Distributors
11.3 Human Tissue Chips Customer
12 World Forecast Review for Human Tissue Chips by Geographic Region
12.1 Global Human Tissue Chips Market Size Forecast by Region
12.1.1 Global Human Tissue Chips Forecast by Region (2024-2029)
12.1.2 Global Human Tissue Chips Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Tissue Chips Forecast by Type
12.7 Global Human Tissue Chips Forecast by Application
13 Key Players Analysis
13.1 Emulate, Inc.
13.1.1 Emulate, Inc. Company Information
13.1.2 Emulate, Inc. Human Tissue Chips Product Portfolios and Specifications
13.1.3 Emulate, Inc. Human Tissue Chips Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Emulate, Inc. Main Business Overview
13.1.5 Emulate, Inc. Latest Developments
13.2 CN Bio Innovations Ltd.
13.2.1 CN Bio Innovations Ltd. Company Information
13.2.2 CN Bio Innovations Ltd. Human Tissue Chips Product Portfolios and Specifications
13.2.3 CN Bio Innovations Ltd. Human Tissue Chips Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 CN Bio Innovations Ltd. Main Business Overview
13.2.5 CN Bio Innovations Ltd. Latest Developments
13.3 TissUse GmbH
13.3.1 TissUse GmbH Company Information
13.3.2 TissUse GmbH Human Tissue Chips Product Portfolios and Specifications
13.3.3 TissUse GmbH Human Tissue Chips Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 TissUse GmbH Main Business Overview
13.3.5 TissUse GmbH Latest Developments
13.4 InSphero AG
13.4.1 InSphero AG Company Information
13.4.2 InSphero AG Human Tissue Chips Product Portfolios and Specifications
13.4.3 InSphero AG Human Tissue Chips Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 InSphero AG Main Business Overview
13.4.5 InSphero AG Latest Developments
13.5 HµRel Corporation
13.5.1 HµRel Corporation Company Information
13.5.2 HµRel Corporation Human Tissue Chips Product Portfolios and Specifications
13.5.3 HµRel Corporation Human Tissue Chips Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 HµRel Corporation Main Business Overview
13.5.5 HµRel Corporation Latest Developments
13.6 AxoSim Technologies LLC
13.6.1 AxoSim Technologies LLC Company Information
13.6.2 AxoSim Technologies LLC Human Tissue Chips Product Portfolios and Specifications
13.6.3 AxoSim Technologies LLC Human Tissue Chips Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 AxoSim Technologies LLC Main Business Overview
13.6.5 AxoSim Technologies LLC Latest Developments
13.7 Kugelmeiers Ltd.
13.7.1 Kugelmeiers Ltd. Company Information
13.7.2 Kugelmeiers Ltd. Human Tissue Chips Product Portfolios and Specifications
13.7.3 Kugelmeiers Ltd. Human Tissue Chips Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Kugelmeiers Ltd. Main Business Overview
13.7.5 Kugelmeiers Ltd. Latest Developments
13.8 Miroculus Inc.
13.8.1 Miroculus Inc. Company Information
13.8.2 Miroculus Inc. Human Tissue Chips Product Portfolios and Specifications
13.8.3 Miroculus Inc. Human Tissue Chips Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Miroculus Inc. Main Business Overview
13.8.5 Miroculus Inc. Latest Developments
13.9 Mimetas BV
13.9.1 Mimetas BV Company Information
13.9.2 Mimetas BV Human Tissue Chips Product Portfolios and Specifications
13.9.3 Mimetas BV Human Tissue Chips Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Mimetas BV Main Business Overview
13.9.5 Mimetas BV Latest Developments
13.10 SynVivo Inc.
13.10.1 SynVivo Inc. Company Information
13.10.2 SynVivo Inc. Human Tissue Chips Product Portfolios and Specifications
13.10.3 SynVivo Inc. Human Tissue Chips Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 SynVivo Inc. Main Business Overview
13.10.5 SynVivo Inc. Latest Developments
13.11 Advanced BioMatrix Inc.
13.11.1 Advanced BioMatrix Inc. Company Information
13.11.2 Advanced BioMatrix Inc. Human Tissue Chips Product Portfolios and Specifications
13.11.3 Advanced BioMatrix Inc. Human Tissue Chips Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Advanced BioMatrix Inc. Main Business Overview
13.11.5 Advanced BioMatrix Inc. Latest Developments
13.12 BIOMIMESYS
13.12.1 BIOMIMESYS Company Information
13.12.2 BIOMIMESYS Human Tissue Chips Product Portfolios and Specifications
13.12.3 BIOMIMESYS Human Tissue Chips Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 BIOMIMESYS Main Business Overview
13.12.5 BIOMIMESYS Latest Developments
13.13 Tara Biosystems, Inc.
13.13.1 Tara Biosystems, Inc. Company Information
13.13.2 Tara Biosystems, Inc. Human Tissue Chips Product Portfolios and Specifications
13.13.3 Tara Biosystems, Inc. Human Tissue Chips Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Tara Biosystems, Inc. Main Business Overview
13.13.5 Tara Biosystems, Inc. Latest Developments
13.14 V&F Bioprocessing, Inc.
13.14.1 V&F Bioprocessing, Inc. Company Information
13.14.2 V&F Bioprocessing, Inc. Human Tissue Chips Product Portfolios and Specifications
13.14.3 V&F Bioprocessing, Inc. Human Tissue Chips Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 V&F Bioprocessing, Inc. Main Business Overview
13.14.5 V&F Bioprocessing, Inc. Latest Developments
13.15 Xylyx Bio, Inc.
13.15.1 Xylyx Bio, Inc. Company Information
13.15.2 Xylyx Bio, Inc. Human Tissue Chips Product Portfolios and Specifications
13.15.3 Xylyx Bio, Inc. Human Tissue Chips Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Xylyx Bio, Inc. Main Business Overview
13.15.5 Xylyx Bio, Inc. Latest Developments
14 Research Findings and Conclusion
※参考情報 ヒト組織チップ(Human Tissue Chips)という概念は、近年の生物医学研究や薬剤開発において非常に注目を集めている技術です。ヒト組織チップとは、ヒトの組織や細胞を模した微小な構造物であり、器官や組織の機能を再現することを目的としています。この技術は、ヒト特有の生物学的特性を持つため、従来の動物モデルに代わる新しいアプローチとして期待されています。 ヒト組織チップの定義は、主に技術的な側面に基づいています。具体的には、3D細胞培養技術や生体誘導材料を用いて設計されたミクロスケールのプラットフォームに、特定のヒト細胞を組み込むことによって、さまざまな生物学的機能を模倣するものです。これにより、組織や器官の応答をより正確に再現でき、薬物の代謝や毒性評価、疾患モデルの作成に役立っています。 ヒト組織チップの特徴としては、まずその高い生物学的再現性が挙げられます。これは、ヒト由来の細胞が使用されるため、動物モデルよりもヒトの生理機能に近い結果が得られることを意味します。また、これらのチップは、通常、マイクロ流体技術を利用しており、流体の流れを制御することで細胞の挙動や環境を調整することが可能です。そのため、在宅環境や病理状態、薬物投与のシナリオを模倣することができ、実験条件の再現性が高まります。 また、ヒト組織チップにはさまざまな種類があります。例えば、肝臓、肺、心臓、神経などの特定の組織や器官を再現したモデルが存在します。肝臓チップでは、肝細胞を使用して、薬物の代謝や肝毒性の試験に利用されることが多いです。肺チップは、呼吸器の疾患モデルやアレルギー反応の研究に用いられています。一方、心臓チップは、心筋細胞を用いた心臓機能や薬物の心臓への影響を評価するモデルとして注目されています。 用途についても多岐にわたります。薬剤のスクリーニングや毒性試験が主な利用シーンですが、難治性疾患の研究や病態の理解、創薬プロセスの向上などにも活用されています。また、個別化医療の分野(プレシジョンメディスン)でも、患者由来の細胞を利用したチップを用いることで、特定の患者に合った治療法の選定に役立つ可能性があります。 さらに、ヒト組織チップは、昨今のオミクス技術(ゲノム、トランスクリプトーム、プロテオームなど)やエピジェネティクスとの組み合わせが期待されています。これにより、より詳細な生物学的メカニズムの解明や、疾患バイオマーカーの発見が促進されることでしょう。 関連技術としては、マイクロ流体技術、3Dバイオプリンティング、細胞培養技術、ナノテクノロジーなどがあります。マイクロ流体技術は、流体の微細な制御によって細胞の環境を変化させることができます。また、3Dバイオプリンティングを使うことで、組織や器官の複雑な立体構造を構築することも可能です。これにより、よりリアルな生理的条件を再現できるようになっています。 これらの技術が組み合わさることで、ヒト組織チップは医療やバイオテクノロジー分野において革新的なツールとしての地位を確立しつつあります。また、規制当局の認可を得ることで、実際の医薬品開発プロセスへの導入が進んでいます。今後は、ヒト組織チップの技術が社会に広く浸透することで、より効率的で倫理的な医療の実現が期待されています。 総じて、ヒト組織チップは、生物医学研究において革新をもたらす可能性があり、熱心な研究と開発が進められています。これにより、ヒトの生体反応を生かした新しい治療法の発見や、個別化医療の実現へ向けた進展が期待されています。未来の医療における重要な役割を担うことが期待されるヒト組織チップの発展に目が離せない状況です。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/